Tumor Treating Fields therapy in platinum-resistant ovarian cancer: Results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized study.
Vergote I, Copeland LJ, Van Gorp T, Laenen A, Scambia G, Thaker PH, Cibula D, Colombo N, Lea J, Gonzalez-Martin A, Korach J, Sehouli J, Monk BJ, Heinzelmann-Schwarz V, Berger R, Buscema J, Lau S, Mądry R, Denys H, Pepin JT, Salutari V, Bagaméri A, Ardizzoia A, Henry S, Cecere SC, Hruda M, Iglesias DA, Manso L, Shai A, O'Malley DM; ENGOT-ov50/GOG-3029/INNOVATE-3 Study Investigators.
Vergote I, et al. Among authors: hruda m.
Eur J Cancer. 2025 Mar 26;219:115306. doi: 10.1016/j.ejca.2025.115306. Epub 2025 Feb 17.
Eur J Cancer. 2025.
PMID: 40010134
Free article.
Clinical Trial.